Cellanome
2 known investors
Cellanome develops a live-cell analysis platform using CellCage technology to create controlled microenvironments that enable researchers to observe cell behavior and molecular changes over time. The platform generates structured multimodal data for life sciences researchers and biopharma companies focused on oncology, neuroscience, immunology, and aging research.
Founders & leadership
OO
Omead OstadanCEO, Board Member
MR
Mostafa RonaghiCofounder, Executive Board Member
Investors · 2
In the news
- Cellanome has filed a notice of an exempt offering of securities to raise $75,930,476.00 in New Funding. - intelligence360intelligence360.news · 2026
- A New Foundational Platform for Biology: Cellanome’s Debut with CEO Omead Ostadanmendelspod.com · 2025
- Healthcare Private Placement and M&A Transactions Review Week Ending Feb 4, 2024 | Silverwood Partnerssilverwoodpartners.com · 2024
- Jay Flatley, other Illumina vets tied to startup Cellanome that raised $150 million - San Francisco Business Timesbizjournals.com · 2024
- Cellanome - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2022
- Cellanome - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2022